Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 October 2020: Clinical Research

Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients

Naro Ohashi 1ABCDEF* , Taro Aoki 1BCE , Takashi Matsuyama 1BCE , Sayaka Ishigaki 2BCE , Shinsuke Isobe 1BCE , Tomoyuki Fujikura 1A , Takuya Hashimoto 3ABDE , Daisuke Tsuriya 3ABDE , Hiroshi Morita 3ABDE , Akihiko Kato 2AD , Hideo Yasuda 1ACDE

DOI: 10.12659/MSM.926086

Med Sci Monit 2020; 26:e926086

Table 3 Relationships between serum uric acid levels and clinical parameters 6 months after sodium-glucose cotransporter-2 inhibitor administration.

RP-value
Age (year)−0.440.030
Height (cm)0.320.13
Body weight (kg)0.360.083
Body mass index (kg/m)0.210.32
Systolic blood pressure (mmHg)−0.470.022
Diastolic blood pressure (mmHg)−0.0470.83
Heart rate (/min)−0.350.24
Hemoglobin (g/dL)−0.110.61
Blood urea nitrogen (mg/dL)0.320.13
Cr (mg/dL)0.76
eGFR (mL/min/1.73 m)−0.510.011
Hemoglobin A1c (%)0.220.31
Low-density lipoprotein cholesterol (mg/dL)0.410.053
Triglyceride (mg/dL)−0.0520.81
Log urinary albumin/Cr (mg/g)0.250.25
Log urinary protein/Cr (g/g)0.170.45
Fractional excretion of glucose (%)0.120.59
Fractional excretion of uric acid (%)0.380.11
eGFR – estimated glomerular filtration rate, Cr – creatinine.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750